BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $407,000 | -21.0% | 2,691 | -23.9% | 0.00% | 0.0% |
| Q2 2022 | $515,000 | -82.9% | 3,534 | -8.1% | 0.00% | -83.3% |
| Q1 2022 | $3,017,000 | +483.6% | 3,847 | +2.7% | 0.01% | +500.0% |
| Q4 2021 | $517,000 | +5.3% | 3,746 | +6.1% | 0.00% | 0.0% |
| Q3 2021 | $491,000 | +122.2% | 3,532 | +55.3% | 0.00% | – |
| Q2 2021 | $221,000 | +51.4% | 2,275 | +6.4% | 0.00% | – |
| Q1 2021 | $146,000 | +97.3% | 2,138 | +148.6% | 0.00% | – |
| Q4 2020 | $74,000 | +164.3% | 860 | +111.8% | 0.00% | – |
| Q3 2020 | $28,000 | -44.0% | 406 | -41.6% | 0.00% | – |
| Q2 2020 | $50,000 | +150.0% | 695 | +18.0% | 0.00% | – |
| Q1 2020 | $20,000 | – | 589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |